Skip to content
value.today

Transcend Medical Inc

Formerly iART Newco I, Inc.

Total raised
$80 M
3 rounds on record
Latest round
$29 M
Mar 2014
First round on record
May 2009
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Transcend Medical Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2014$29 MNo. 3$10 to $50 million

Transcend Medical Inc: Raise no. 3, Mar 2014

Investors in this round

18 investors had bought by the notice of Jan 5, 2015: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$29 M of $29 M offered
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brian Walsh · Executive Officer, Director
  • Abhijeet Angela Lele · Director
  • Art Angela Taylor · Director
  • Dan W. Galles · Director
  • David W. Stassen · Director
  • Evgeny Angela Zaytsev · Director
  • Jim W. Glasheen · Director
  • K. Angela Macfarlane · Director
  • Robert C. Bellas, Jr. · Director
  • Wende W. Hutton · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brian Walsh, President. Newest notice filed Jan 5, 2015 (1 amendment). Read the notice at the SEC.

equitySEC
Jun 2011$28 MNo. 2$10 to $50 million

Transcend Medical Inc: Raise no. 2, Jun 2011

Investors in this round

15 investors had bought by the notice of Jul 14, 2011: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$28 M of $28 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brian Walsh · Executive Officer, Director
  • Abhijeet Lele · Director
  • Al Wiegman · Director
  • David Stassen · Director
  • Eugene de Juan, Jr., M.D. · Director
  • Jim Glasheen · Director
  • Reza Zadno · Director
  • Robert Bellas, Jr. · Director
  • Wende Hutton · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brian Walsh, President. Newest notice filed Jul 14, 2011. Read the notice at the SEC.

equitySEC
May 2009$23 MNo. 1$10 to $50 million

Transcend Medical Inc: Raise no. 1, May 2009

Investors in this round

12 investors had bought by the notice of Aug 20, 2009: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$23 M of $41 M offered; $18 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brian Walsh · Executive Officer, Director
  • Al Wiegman · Director
  • David Stassen · Director
  • Eugene de Juan, Jr., M.D. · Director
  • Jim Glasheen · Director
  • Reza Zadno · Director
  • Robert Bellas, Jr. · Director
  • Wende Hutton · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Offering Amount: $41,000,000.33; Total Amount Sold: $23,428,571.68; Total Remaining to be Sold: $17,571,428.65”

Signed by Philip H. Oettinger, Secretary. Newest notice filed Aug 20, 2009 (1 amendment). Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Transcend Medical Inc chose not to state its revenue in its newest notice of a funding round (Jan 2015).

    SEC Form D · Jan 2015

  • The industry group it chose in its notices: Other.

    SEC Form D · Jan 2015

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Transcend Medical Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Transcend Medical Inc
NameRoleNamed in
Brian WalshExecutive officerJan 2015
Tsontcho Angela IanchulevExecutive officerApr 2014
Abhijeet Angela LeleDirectorJan 2015
Art Angela TaylorDirectorJan 2015
Brian WalshDirectorJan 2015
Dan W. GallesDirectorJan 2015
David W. StassenDirectorJan 2015
Evgeny Angela ZaytsevDirectorJan 2015
Jim W. GlasheenDirectorJan 2015
K. Angela MacfarlaneDirectorJan 2015
Robert C. Bellas, Jr.DirectorJan 2015
Wende W. HuttonDirectorJan 2015
Abhijeet LeleDirectorJul 2011
Al WiegmanDirectorJul 2011
David StassenDirectorJul 2011
Eugene de Juan, Jr., M.D.DirectorJul 2011
Jim GlasheenDirectorJul 2011
Reza ZadnoDirectorJul 2011
Robert Bellas, Jr.DirectorJul 2011
Wende HuttonDirectorJul 2011